JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265558

Human PSMD5 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

PSMD5 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1.

View Alternative Names

26S protease subunit S5 basic, 26S proteasome non-ATPase regulatory subunit 5, 26S proteasome subunit S5B, PSMD5_HUMAN, Protease 26S, subunit 5B, Proteasome (prosome, macropain) 26S subunit, non ATPase, 5, Proteasome 19S S5B, Proteasome 26S subunit, non ATPase, 5, S5B

1 Images
Sanger Sequencing - Human PSMD5 knockout HeLa cell line (AB265558)
  • Sanger seq

Unknown

Sanger Sequencing - Human PSMD5 knockout HeLa cell line (AB265558)

Homozygous : 1 bp insertion in exon 1.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 1

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255928). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265558-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265558 Human PSMD5 knockout HeLa cell line", "number":"AB265558-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265558-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265558 Human PSMD5 knockout HeLa cell line", "number":"AB265558-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
PSMD5
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PSMD5 also known as S13 or 26S proteasome non-ATPase regulatory subunit 5 plays an essential role in the ubiquitin-proteasome system. It has a molecular mass of approximately 39 kDa. PSMD5 is a component of the 26S proteasome complex a structure important for protein degradation in cells. This protein locates in various tissues especially in high-protein turnover areas such as the liver skeletal muscle and heart.
Biological function summary

The protein influences the breakdown of ubiquitinated proteins. PSMD5 forms part of the 19S regulatory subunit of the 26S proteasome complex. The 19S regulatory complex is significant for recognizing and unfolding ubiquitinated substrates guiding their entry into the proteolytic 20S core. By participating in this process PSMD5 aids in maintaining protein quality control and regulating the cell cycle.

Pathways

PSMD5 affects the ubiquitin-proteasome degradation pathway an important regulator of protein turnover. This pathway is essential for numerous cellular processes including cell cycle progression and signal transduction. PSMD5 interacts with proteins such as ubiquitin and other subunits of the proteasome complex to facilitate the degradation of proteins tagged for destruction. It also plays a part in pathways linked to NF-kB signaling where it may interface with proteins like IκB a known inhibitor of the NF-kB pathway.

PSMD5 connects to conditions such as cancer and neurodegenerative diseases. The protein's role in the regulation of protein degradation implicates it in diseases where protein homeostasis goes awry. For example alterations in proteasome activity can lead to the accumulation of damaged proteins a hallmark of neurodegenerative disorders. In cancer dysregulation of protein degradation may contribute to uncontrolled cell growth and survival. Elevated levels of ubiquitin-like proteins often accompany such pathological conditions highlighting PSMD5's involvement.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com